
Nektar Therapeutics (NKTR) EPS is poised to hit -3.03 next quarter: How Investors Can Make It Count the Most?
Nektar Therapeutics (NASDAQ: NKTR) established initial surge of 10.48% at $26.67, as the Stock market unbolted on Thursday, before settling in for the price of